[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364838-105":59,"doc-detail-364838-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ursodeoxycholic-acid-exhibits-greater-inhibitory-effects-on-cancerous-hct116-colon-cells-than-on-noncancerous-ncm460-colon-cells","Ursodeoxycholic Acid Exhibits Greater Inhibitory Effects on Cancerous HCT116 Colon Cells than on Noncancerous NCM460 Colon Cells","","Ursodeoxycholic acid (UDCA), a hydrophilic bile acid, is explored for anticancer activity because it has known anti-inflammatory effects and may attenuate colon carcinogenesis. The work tests the hypothesis that UDCA preferentially suppresses proliferation of cancerous colon cells with limited impact on noncancerous cells. Human NCM460 and HCT116 cell models are treated with UDCA (0 to 0.4 mM) for 48 h using biochemical assays, western blotting, PCR arrays, cell cycle, apoptosis, and immunofluorescence to define proliferation inhibition and molecular pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ursodeoxycholic-acid-exhibits-greater-inhibitory-effects-on-cancerous-hct116-colon-cells-than-on-noncancerous-ncm460-colon-cells/364838/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ursodeoxycholic-acid-exhibits-greater-inhibitory-effects-on-cancerous-hct116-colon-cells-than-on-noncancerous-ncm460-colon-cells/364838.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What hypothesis does the study test about UDCA?","Question",{"text":112,"@type":113},"The study hypothesizes that UDCA preferentially inhibits cancerous colon cell proliferation while having a minimal effect on noncancerous colon cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cell models are used to compare UDCA effects?",{"text":117,"@type":113},"Cancerous HCT116 colon cells and noncancerous NCM460 colon cells are used to evaluate differences in UDCA response.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular pathways are implicated in UDCA’s anti-cancer effects?",{"text":121,"@type":113},"UDCA’s effects involve cell cycle and apoptosis with signaling through ERK1/2/c-Myc/p21, including reduced c-Myc and increased p21 expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364838,1791626563,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Article  \nUrsodeoxycholic Acid Exhibits Greater Inhibitory Effects on Cancerous HCT116 Colon Cells than on Noncancerous NCM460 Colon Cells  \nHuawei Zeng 1, *, Bryan D. Safratowich 1, Wen-Hsing Cheng 2 and Mary Briske-Anderson 1  \nAcademic Editor: Alessandro Granito  \nReceived: 16 February 2025  \nRevised: 12 March 2025  \nAccepted: 16 March 2025  \nPublished: 19 March 2025  \nCitation: Zeng, H.; Safratowich, B.D.; Cheng, W.-H.; Briske-Anderson, M. UrsodeoxycholicAcid Exhibits Greater Inhibitory Effects on Cancerous HCT116 Colon Cells than on Noncancerous NCM460 Colon Cells. Nutrients 2025, 17, 1072 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)nu17061072  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 USDA-ARS Grand Forks Human Nutrition Research Center, Grand Forks, ND 58203, USA; [bryan.safratowich@usda.gov](bryan.safratowich@usda.gov) (B.D.S.); [mbanders71@gmail.com](mbanders71@gmail.com) (M.B.-A.)  \n2 Department of Nutrition and Food Sciences, Texas Woman’s University, Denton, TX 76209, USA; [wcheng1@twu.edu](wcheng1@twu.edu)  \n* [Correspondence: huawei.zeng@usda.gov](Correspondence: huawei.zeng@usda.gov)  \nAbstract: Background/Objectives: Ursodeoxycholic acid (UDCA), a hydrophilic bile acid, exhibits anti-inflammatory effects and attenuates the process of colon carcinogenesis. Certain healthy diets increase colonic UDCA concentrations, but its anticancer mechanistic actions remain largely unknown. We hypothesize that UDCA preferentially inhibits cancerous colon cell proliferation with a minimal effect on noncancerous colon cells. Methods: With human noncancerous NCM460 colon cell and cancerous HCT116 colon cell culture models, we performed biochemical, western blotting, PCR array, cell cycle, apoptosis, and immunofluorescent assays to determine the effects of UDCA treatment on colon cell proliferation and the underlying molecular mechanisms. Results: The inhibitory potential of UDCA against cell proliferation (via cell cycle arrest and apoptosis) was 90% greater in cancerous HCT116 cells than noncancerous NCM460 cells when treated with UDCA (0 to 0.4 mM) for 48 h. In UDCA-treated HCT116 cells, we identified 18 genes with ≥80% change (compared to untreated cells) in mRNA levels out of 93 apoptotic genes which were involved in caspase, death receptor, and NFκB pathways. At the molecular level, 0.4 mM UDCA reduced the protein level of the proto-oncogenic c-Myc gene but increased the putative tumor suppressor p21 gene (≥100%) via the ERK1/2/c-Myc/p21 pathway, which regulates cell cycle and apoptosis. These data are consistent with lower c-Myc but higher p21 expression in normal colon tissues compared to cancerous colon tissues. Conclusions: Collectively, UDCA inhibits cancerous HCT116 colon cells to a higher degree than in noncancerous NCM460 colon cells through cell cycle and apoptosis involving ERK1/2/c-Myc/p21 signaling.  \nKeywords: apoptosis; bile acid; cancer; cell cycle; pathway; proliferation  \n1. Introduction  \nColorectal cancer (CRC) is a serious health issue and a primary cause of mortality in the United States. About 50% of the population may have been diagnosed with a colorectal tumor by around the age of 70 years in the Western world [1,2] . Fortunately, about half of CRC cases can be prevented by adopting positive critical lifestyle habits such as a healthy diet and physical activity [3] . Tumorigenesis is a multistep process, and colon cancer is a chronic disease that can take 10 to 15 years to develop from a precancerous polyp into a full-blown cancer in which cell proliferation is out of control in the colon. While it is becoming increasingly evident that certain nutrients can prevent CR","cbCair0SwUENbSOc","https://ap.wps.com/l/cbCair0SwUENbSOc","pdf",4379637,17,"English","# Abstract\n# Introduction\n## Colorectal cancer background and prevention\n## Bile acid metabolism and UDCA rationale\n# Methods\n## Cell culture models\n## Assays and molecular analyses\n# Results\n## Proliferation inhibition in cancer vs noncancer cells\n## Gene expression and pathway effects\n# Conclusions","[{\"question\":\"What hypothesis does the study test about UDCA?\",\"answer\":\"The study hypothesizes that UDCA preferentially inhibits cancerous colon cell proliferation while having a minimal effect on noncancerous colon cells.\"},{\"question\":\"Which cell models are used to compare UDCA effects?\",\"answer\":\"Cancerous HCT116 colon cells and noncancerous NCM460 colon cells are used to evaluate differences in UDCA response.\"},{\"question\":\"What molecular pathways are implicated in UDCA’s anti-cancer effects?\",\"answer\":\"UDCA’s effects involve cell cycle and apoptosis with signaling through ERK1/2/c-Myc/p21, including reduced c-Myc and increased p21 expression.\"}]","Ursodeoxycholic Acid Exhibits Greater Inhibitory Effects on Cancerous HCT116 Colon Cells than on Noncancerous NCM460 Colon Cells | PDF",1790159194,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b75577342aca41c9e84c8f7f745a35ac.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4a98fc7459717d3371f91a48046f677.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7792f128c585f83f08efce451489616.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/465351a4b11522bb7fee55c058dee674.webp",980,1385]